Mentioned On
Episode Mentions
MIT Technology Review Narrated · Apr 15, 2026
This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity”
“Biotech company developing VEGF and follistatin gene therapies for muscle growth and longevity, operating in Prospera with planned clinical trials starting January 2026”
Gene therapy regulation and special economic zonesVEGF (vascular endothelial growth factor) therapy safety and efficacyFollistatin gene therapy for muscle growth
View Analysis